Although Foxf2 expression was not predictive for metastasis formation or survival in the total patient pool (Fig. 6c), high expression of Foxf2 correlated with poor overall survival in patients with luminal subtype B breast cancer (Fig. 6d). The gene discussed is FOXF2; the disease is breast carcinoma.